Evidence map›Paper›PMID 40338280›Full record

ArticleWorld journal of urology2025

Characteristics of men using non-prescription medicines to treat their lower urinary tract symptoms.

Martin C Michel, Kurt Miller, Tim Schneider, Christian Ude, Matthias Oelke

Abstract read
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Martin C MichelDepartment of Pharmacology, University Medical Center, Johannes Gutenberg University, Mainz, Germany. marmiche@uni-mainz.de.
Kurt MillerDepartment of Urology, Charité, Berlin, Germany.
Tim SchneiderPraxisklinik Urologie Rhein-Ruhr, Mülheim, Germany.
Christian UdeStern Pharmacy, Darmstadt, Germany.
Matthias OelkeInterdisciplinary Pelvic Floor Center, Kantonsspital Frauenfeld and Münsterlingen, Spital Thurgau AG, Frauenfeld, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMany men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) opt for self-management with non-prescription treatments. We wished to better characterize these men and understand their motivation and experience.

methodsWe conducted an anonymous survey among 477 users of non-prescription treatments for LUTS.

resultsParticipating men had a mean age (64.3 ± 7.8 years) and IPSS (17.7 ± 7.9 points) comparable to users of prescription medicines in non-interventional studies, indicating that they were not primarily motivated by mild symptom intensity. They had realistic expectations on efficacy and tolerability. While reasons for preference for a non-prescription treatment varied, 40.0% stated a wish to avoid 'chemical' and, vice-versa, to use 'natural' treatments. The choice of a specific treatment was largely driven by prior experience, but recommendations from a physician or the pharmacy as well as advertisements also played a role. About two thirds of participants reported to be repeat users and purchasing the same product each time. However, less than a quarter of participants appear to use the non-prescription treatment continuously.

conclusionsMen self-managing their LUTS/BPH are similar to those using prescription drugs based on age and symptom severity. Their main reasons to prefer non-prescription medicines relate to the wish to avoid 'chemical' and the preference for 'natural' treatments. Most of them are repeat users of the same product but use it only intermittently.

Indexed as

Lower Urinary Tract SymptomsNonprescription DrugsProstatic HyperplasiaSelf-ManagementAgedHumansMaleMiddle AgedSurveys and QuestionnairesNonprescription DrugsLUTS/BPHOver-the-counter medicationsPatient preferencesPhytotherapySurvey

Identifiers

PMID40338280
PMCPMC12062051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.